Skip to Content for Lucentis Clinical Trial Patient Profile Menu for Lucentis Clinical Trial Patient Profile About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Lucentis Clinical Trial Patient Profile

Jim

Jim

Interview Transcript

Jim Video
Jim:
"I've been married very happily for 54 years - best thing that ever happened to me. My favorite hobby is probably scuba diving, which I've been doing for about 45 years, and golfing.

I was playing golf in Illinois, and I noticed that the lines in the scorecard were a little wavy. I noticed other things like light poles being wavy. There's no mistaking it when it happens. I was diagnosed in November 2007 with wet AMD."

Dot (Jim's Wife):
"I thought, my god, everything he does is visual. He loves his boat, and he spends so much time on that boat. He would have to give it up. His whole life would've changed."

Jim:
"I went to see my doctor, and he prescribed Lucentis. And almost immediately upon starting the shots, my vision started improving. I recall that it was 20/60 on one visit, and then it was 20/50, and then it was, you know, 20/40, then it was 20/30. And of course, 20/20 would be perfect vision."

Dot (Jim's Wife):
"Now that he has Lucentis, his life is just going right along, and that's a wonderful thing."

Jim:
"I intend to keep on Lucentis as long as possible and doing whatever I can to keep that vision. It's a very precious thing."

Product Indication Lucentis® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration.

Important Safety Information Like any prescription medication, Lucentis is not for everyone. People should not use Lucentis if they have an infection in or around the eye.

Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with Lucentis. Increases in eye pressure have been seen within 1 hour of an injection. An eye doctor should monitor a patient's eye pressure and eye health during the week after the injection.

If a patient's eye becomes red, sensitive to light, painful, or has a change in vision, they should seek immediate care from their eye doctor.

Although uncommon, conditions associated with eye- and non-eye-related blood clots (arterial thromboembolic events) may occur.

Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.

The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in the eye, and increased tears. The most common non-eye-related side effects were nose and throat infection, headache, and respiratory and urinary tract infections.

Lucentis is for prescription use only.

Please see the full Product Information for additional safety information.

Individual results may vary.